Globus Medical, Inc. (BMV:GMED)

Globus Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	2,939	2,519	1,568	1,023	958.1
Revenue Growth (YoY)	16.65%	60.62%	53.34%	6.76%	21.43%
Cost of Revenue	957.8	1,035	548.17	263.73	239.22
Gross Profit	1,981	1,484	1,020	759.12	718.88
Selling, General & Admin	1,178	981.36	643.84	432.12	408.15
Depreciation & Amortization Expenses	118.19	119.37	51.03	17.74	18.53
Research & Development	147.25	163.75	124.01	73.02	97.35
Other Operating Expenses	57.38	53.4	68.27	8.3	22.91
Operating Income	479.82	165.99	133.14	227.95	171.95
Total Non-Operating Income (Expense)	125.25	-45.27	32.25	15.07	8.45
Pretax Income	605.07	120.72	165.39	243.02	180.41
Provision for Income Taxes	67.2	17.74	42.52	52.85	31.22
Net Income	537.87	102.98	122.87	190.17	149.19
Net Income to Common	537.87	102.98	122.87	190.17	149.19
Net Income Growth	422.28%	-16.19%	-35.39%	27.47%	45.86%
Shares Outstanding (Basic)	135	136	113	100	101
Shares Outstanding (Diluted)	137	138	115	103	104
Shares Change (YoY)	-0.58%	20.27%	11.68%	-0.95%	1.39%
EPS (Basic)	3.98	0.76	1.09	1.89	1.48
EPS (Diluted)	3.92	0.75	1.07	1.85	1.44
EPS Growth	422.67%	-29.91%	-42.16%	28.47%	8.27%
Free Cash Flow	588.77	405.21	165.23	104.42	219.38
Free Cash Flow Growth	45.30%	145.25%	58.23%	-52.40%	62.34%
Free Cash Flow Per Share	4.30	2.94	1.44	1.02	2.12
Gross Margin	67.41%	58.90%	65.05%	74.22%	75.03%
Operating Margin	16.33%	6.59%	8.49%	22.29%	17.95%
Profit Margin	18.30%	4.09%	7.83%	18.59%	15.57%
FCF Margin	20.03%	16.08%	10.53%	10.21%	22.90%
EBITDA	756.66	419.38	278.67	296.2	241.82
EBITDA Margin	25.75%	16.65%	17.77%	28.96%	25.24%
EBIT	479.82	165.99	133.14	227.95	171.95
EBIT Margin	16.33%	6.59%	8.49%	22.29%	17.95%
Effective Tax Rate	11.11%	14.69%	25.71%	21.75%	17.30%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.